American Journal of Gastroenterology Publishes Data from HighTide Therapeutics' Phase 2 Study of HTD1801 Treatment in Primary Sclerosing Cholangitis
Nov 16, 2022 23:00 HKT |  |
|
InaVac gets emergency approval from BPOM
Nov 14, 2022 11:30 HKT |  |
|
CR Pharmaceutical Becomes Constituent of MSCI China Index Once Again
Nov 14, 2022 08:59 HKT |  |
|
Healthcare and Medical Leaders Gather to Shape the Future of Global Health
Nov 11, 2022 20:00 HKT |  |
|
Novotech Chairs BioCentury Summit Workshop on How to Build and Finance an East-West MRCT Strategy
Nov 11, 2022 17:00 HKT |  |
|
Prenetics Announces Record Third Quarter 2022 Financial Results and Raises Full Year 2022 Revenue and EBITDA Guidance
Nov 10, 2022 21:36 HKT |  |
|
Spotlight on Healthcare Collaboration and Innovation at Asia Summit on Global Health and HK International Medical and Healthcare Fair
Nov 10, 2022 18:00 HKT | |
|
Led by Legend Capital, PureFDA Secures Over CNY100 million in the Series B Round
Nov 10, 2022 14:26 HKT |  |
|
Bintai Kinden Ventures into Telco through Agreement with MN Permai Netcom
Nov 10, 2022 13:00 HKT |  |
|
Sirnaomics Doses the First Patient in Phase I Clinical Trial of RNAi Therapeutic STP705 in Adults Undergoing Abdominoplasty for Medical Aesthetics Treatment
Nov 08, 2022 08:43 HKT | |
|
Legend Capital Portfolio Company Giant Biogene Successfully Lists on the HKEX
Nov 07, 2022 15:49 HKT | |
|
Handover of National Centre for Pandemic and Infection Diseases in Myanmar; Advanced Facility Built with Donation from AW Foundation
Nov 05, 2022 12:45 HKT |  |
|
SinoMab Announces Appointment of Mr. Shanchun WANG as the President (China) of the Company
Nov 04, 2022 17:47 HKT |  |
|
Led by Legend Capital, ClinBrain Completes Nearly CNY200 million Series C Round
Nov 01, 2022 18:05 HKT | |
|
Led by Legend Capital, Easy-Flow Raises Tens of Millions of CNY in Angel Round
Nov 01, 2022 17:51 HKT | |
|
Inaugural International Healthcare Week promotes Hong Kong as leading healthcare hub
Oct 31, 2022 19:00 HKT | |
|
Zhaoke Ophthalmology's Partner Vyluma Announces Positive Results from Phase III CHAMP Study of NVK002 for Treatment of Myopia Progression in Children
Oct 28, 2022 09:45 HKT |  |
|
Malaysian Genomics Signs Strategic Collaboration Agreement for Expansion in the UAE
Oct 26, 2022 19:00 HKT |  |
|
Clinical Research Opportunities in China and the Path to USFDA Approval - Whitepaper
Oct 25, 2022 18:00 HKT | |
|
Olympus Announces Leadership Succession Plan
Oct 21, 2022 14:00 HKT |  |
|